EU Health Regulator Clears Use of AI Tool in Fatty Liver Disease Trials (Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI ...
A Chinese research team has developed an artificial intelligence (AI) tool that predicts liver cancer recurrence risk with 82.2 per cent accuracy, according to a study recently published in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback